Assessing awareness of hypoglycemia in children and adolescents with type 1 diabetes: Evaluation of established questionnaires

Objective: To evaluate the use of two questionnaires assessing awareness of hypoglycemia, in a pediatric type 1 diabetes (T1D) population.

Methods: Prospective observational study with children (aged 9-18 years) and parents (for children aged 2-11 years) answering the Gold and Clarke questionnaires assessing awareness of hypoglycemia. Psychometric properties of the questionnaires were evaluated, and the most appropriate cut-off score to classify participants as having normal vs impaired awareness of hypoglycemia (IAH) was determined by ability to recognize subsequent hypoglycemia and hypoglycemia severity, documented in a 4-week blood glucose diary. Questionnaires were readministered at follow-up assessment approximately 1.5 years later.

Results: In total, 112 participants (51% male) with median (IQR) age 13.7 (11.1-15.8) years, T1D duration 4.7 (2.2-7.8) years, and HbA1c 62 (57-73) mmol/mol (7.8%) were included. Both questionnaires demonstrated acceptable psychometric properties. Using score ≥3 to classify IAH gave a prevalence of IAH of 41% (Gold) and 22% (Clarke). When classified using the Gold questionnaire, IAH participants had higher incidences of mild asymptomatic hypoglycemia, whereas with the Clarke questionnaire, they had higher incidences of clinically significant and severe hypoglycemia. Subgroup analyses confirmed these associations only in participants aged ≥9 years. Follow-up was completed in 90% of the participants, and a change of awareness status was observed in 22% to 36%.

Conclusions: The Gold and Clarke questionnaires may be used to assess awareness of hypoglycemia in pediatric T1D in those ≥9 years of age, but the more detailed Clarke questionnaire has higher specificity and is superior in predicting risk of clinically significant hypoglycemia.

Keywords: hypoglycemia; impaired awareness of hypoglycemia; pediatric diabetes; type 1 diabetes.

© 2019 The Authors. Pediatric Diabetes published by John Wiley & Sons Ltd.

Similar articles

Graveling AJ, Noyes KJ, Allerhand MH, Wright RJ, Bath LE, Deary IJ, Frier BM. Graveling AJ, et al. Pediatr Diabetes. 2014 May;15(3):206-13. doi: 10.1111/pedi.12077. Epub 2013 Sep 19. Pediatr Diabetes. 2014. PMID: 24102825

Abraham MB, Gallego PH, Brownlee WM, Smith GJ, Davis EA, Jones TW. Abraham MB, et al. Pediatr Diabetes. 2017 Dec;18(8):729-733. doi: 10.1111/pedi.12460. Epub 2016 Nov 11. Pediatr Diabetes. 2017. PMID: 27862736

Lin YK, Hung M, Sharma A, Chan O, Varner MW, Staskus G, Fisher SJ. Lin YK, et al. Endocr Pract. 2019 Jun;25(6):517-525. doi: 10.4158/EP-2018-0527. Epub 2019 Mar 13. Endocr Pract. 2019. PMID: 30865520 Free PMC article.

Yu X, Fan M, Zhao X, Ding Y, Liu X, Yang S, Zhang X. Yu X, et al. Diabet Med. 2023 Sep;40(9):e15129. doi: 10.1111/dme.15129. Epub 2023 May 18. Diabet Med. 2023. PMID: 37143390 Review.

Yeoh E, Choudhary P, Nwokolo M, Ayis S, Amiel SA. Yeoh E, et al. Diabetes Care. 2015 Aug;38(8):1592-609. doi: 10.2337/dc15-0102. Diabetes Care. 2015. PMID: 26207053 Review.

Cited by

Habte-Asres HH, Jiang Y, Rosenthal M, Wheeler DC. Habte-Asres HH, et al. BMJ Open Diabetes Res Care. 2024 Feb 1;12(1):e003730. doi: 10.1136/bmjdrc-2023-003730. BMJ Open Diabetes Res Care. 2024. PMID: 38302432 Free PMC article.

Abraham MB, Karges B, Dovc K, Naranjo D, Arbelaez AM, Mbogo J, Javelikar G, Jones TW, Mahmud FH. Abraham MB, et al. Pediatr Diabetes. 2022 Dec;23(8):1322-1340. doi: 10.1111/pedi.13443. Pediatr Diabetes. 2022. PMID: 36537534 Free PMC article. No abstract available.

Rubin NT, Seaquist ER, Eberly L, Kumar A, Mangia S, Öz G, Moheet A. Rubin NT, et al. J Endocr Soc. 2022 Aug 1;6(9):bvac107. doi: 10.1210/jendso/bvac107. eCollection 2022 Sep 1. J Endocr Soc. 2022. PMID: 35935070 Free PMC article.

Messaaoui A, Tenoutasse S, Hajselova L, Crenier L. Messaaoui A, et al. Diabetes Ther. 2022 Sep;13(9):1671-1681. doi: 10.1007/s13300-022-01297-x. Epub 2022 Jul 23. Diabetes Ther. 2022. PMID: 35870074 Free PMC article.

References

REFERENCES

    1. Graveling AJ, Frier BM. Impaired awareness of hypoglycaemia: a review. Diabetes Metab. 2010;36(suppl 3):S64-S74.
    1. Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care. 1994;17(7):697-703.
    1. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care. 1995;18(4):517-522.
    1. Geddes J, Schopman JE, Zammitt NN, Frier BM. Prevalence of impaired awareness of hypoglycaemia in adults with type 1 diabetes. Diabetic Med. 2008;25(4):501-504.
    1. Ly TT, Gallego PH, Davis EA, Jones TW. Impaired awareness of hypoglycemia in a population-based sample of children and adolescents with type 1 diabetes. Diabetes Care. 2009;32(10):1802-1806.